Skip To Main Content
Jennifer Rigby on Muck Rack

Jennifer Rigby

Verified
  • Global Health Correspondent, Reuters
London
As seen in: Reuters, Apple News, G1 Globo, MSN, MSN Australia, MSN Brasil, MSN Canada, MSN Ireland, MSN New Zealand, MSN Singapore, MSN UK and
Global health correspondent @Reuters, formerly @TelGlobalHealth and @Channel4News, briefly in Myanmar
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jennifer

Contact Jennifer, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Study: Fewer kids got US-backed HIV treatment after aid cuts

|
By Jennifer Rigby Verified
| Billings Gazette Verified
Around 77,000 fewer children worldwide received HIV treatment supported by the U.S. in the year to October 2025 than in the previous fiscal year, according to a study that found declines after the Trump administration's cuts and changes to foreign aid. kAm%96 DEF5J C676CD @?=J E@ &]$]\DFAA@CE65 42C6[ 2?5 D@>6 @7 E96 49:=5C6?
Open in Who Shared Issue with article?

Ebola sem controle no Congo: quais vacinas estão em desenvolvimento?

|
By Mariam Sunny, Jennifer Rigby Verified
| CNN Brasil Verified
Autoridades de saúde globais estão correndo contra o tempo para identificar opções médicas que ajudem a conter um surto de Ebola no leste da República Democrática do Congo, ligado à cepa Bundibugyo do vírus. Ao contrário da cepa Zaire, mais comum, não existem vacinas ou tratamentos aprovados para o Bundibugyo. O surto mais recente resultou em 2.473 casos confirmados no Congo, incluindo 999 mortes, segundo dados do governo. O vírus ebola Bundibugyo , ou BDBV, tem uma taxa de mortalidade de até 40%.
Open in Who Shared Issue with article?

What Bundibugyo Ebola vaccines and treatments are under development

|
By Mariam Sunny, Jennifer Rigby Verified
| MarketScreener
July 22 (Reuters) - Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked to the Bundibugyo strain of the virus. Unlike for the more common Zaire strain, there are no approved vaccines or treatments for Bundibugyo. The latest outbreak has led to 2,473 confirmed cases in Congo, including 999 deaths, government data showed. Bundibugyo ebolavirus, or BDBV, has a fatality rate of up to 40%.
Open in Who Shared View Duplicates (2) Issue with article?
See all 19,338 licensed articles (22,341 Total)